Please use this identifier to cite or link to this item:
Title: HPV-16 E7 expression up-regulates phospholipase D activity and promotes rapamycin resistance in a pRB-dependent manner
Authors: Rabachini, Tatiana
Boccardo, Enrique
Andrade, Rubiana
Perez, Katia Regina [UNIFESP]
Nonogaki, Suely
Cuccovia, Iolanda Midea
Villa, Luisa Lina
Keywords: HPV
Phosphatidic acid
Issue Date: 2018
Publisher: Biomed Central Ltd
Citation: Bmc Cancer. London, v. 18, p. -, 2018.
Abstract: Background: Human Papillomavirus (HPV) infection is the main risk factor for the development and progression of cervical cancer. HPV-16 E6 and E7 expression is essential for induction and maintenance of the transformed phenotype. These oncoproteins interfere with the function of several intracellular proteins, including those controlling the PI3K/AKT/mTOR pathway in which Phospolipase D (PLD) and Phosphatidic acid (PA) play a critical role. Methods: PLD activity was measured in primary human keratinocytes transduced with retroviruses expressing HPV-16 E6, E7 or E7 mutants. The cytostatic effect of rapamycin, a well-known mTOR inhibitor with potential clinical applications, was evaluated in monolayer and organotypic cultures. Results: HPV-16 E7 expression in primary human keratinocytes leads to an increase in PLD expression and activity. Moreover, this activation is dependent on the ability of HPV-16 E7 to induce retinoblastoma protein (pRb) degradation. We also show that cells expressing HPV-16 E7 or silenced for pRb acquire resistance to the antiproliferative effect of rapamycin. Conclusion: This is the first indication that HPV oncoproteins can affect PLD activity. Since PA can interfere with the ability of rapamycin to bind mTOR, the use of combined strategies to target mTOR and PLD activity might be considered to treat HPV-related malignancies.
ISSN: 1471-2407
Other Identifiers:
Appears in Collections:Artigo

Files in This Item:
File SizeFormat 
WOS000431267000015.pdf2.87 MBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.